Guggenheim lowered the firm’s price target on Globant (GLOB) to $125 from $150 and keeps a Buy rating on the shares. Globant’s negative outlook anticipated for calendar year 2025 reinforces the level of demand uncertainty faced by the industry, the analyst says. Ongoing deal and project ramp delays drove management to cut its expected calendar 2025 revenue growth to “at least” 2% year-over-year in constant currency, or flat organically, and while the magnitude of the cut is “disappointing,” the firm remains Buy-rated over the medium term as it thinks the risk/reward “appears positively skewed at these levels,” the analyst tells investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLOB:
- Globant price target lowered to $125 from $160 at TD Cowen
- Strategic Adjustments and AI-Powered Model Drive Buy Rating for Globant SA Despite Short-Term Challenges
- Globant downgraded to Neutral at Goldman following miss and lower report
- Globant downgraded to Neutral from Buy at Goldman Sachs
- Globant SA: Buy Rating Maintained Amid Short-Term Challenges and Attractive Risk-Reward Scenario